Open Access

Genetic predisposition in female patients with triple‑negative breast cancer

  • Authors:
    • Zornitsa Bogomilova Kamburova
    • Savelina Lubenova Popovska
    • Katya Stefanova Kovacheva
    • Dobromir Dimitrov Dimitrov
    • Slavena Enkova Nikolova
  • View Affiliations

  • Published online on: December 5, 2023     https://doi.org/10.3892/wasj.2023.217
  • Article Number: 2
  • Copyright : © Kamburova et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Triple‑negative breast cancer (TNBC) is an immunohistochemical tumor type characterized by the absence of estrogen, progesterone and human epidermal growth factor receptors. Its complexity renders it difficult to select an effective therapy. TNBC accounts for ~15% of all breast cancer cases in the Caucasian population and 35% among African American women; it is most common in women <40 years of age. The present study examined the spectrum and frequency of germline mutations in genes with a high and moderate penetrance in a cohort of women with TNBC. Molecular analysis was performed with a multigene panel of 94 genes for cancer predisposition using next‑generation sequencing. The mean age of the TNBC cohort at the time of diagnosis was 44 years, 14 years younger than the mean age of the non‑TNBC cohort (58 years). The results revealed a high frequency (41.2%) of pathogenic/likely pathogenic variants in susceptible genes in women with TNBC. Pathogenic germline variants in BRCA1/2 were found in 32% of the women (70% of pathogenic variants detected), and alterations in other predisposing genes (FANCM, CDKN2A and BLM) were found in 9% of the women. The data of all the patients with TNBC studied revealed a family history of cancer in 30% of the cases; most frequently, this involved relatives with breast cancer (11.8%). In the present study, the most frequent variant detected (in 11.8% of patients with TNBC) was a pathogenic variant in the BRCA1 gene (c.5266dup). The recommendations of genetic counselors for patients with a pathogenic BRCA1/2 germline variant followed accepted prevention and risk reduction guidelines. By contrast, in the case of a detected pathogenic germline variant in genes with a moderate or low penetrance, the recommendations depended on the assessment of genetic counselors based on age at diagnosis, family history, the gene affected and the pathogenic variant.
View References

Related Articles

Journal Cover

January-February 2024
Volume 6 Issue 1

Print ISSN: 2632-2900
Online ISSN:2632-2919

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kamburova ZB, Popovska SL, Kovacheva KS, Dimitrov DD and Nikolova SE: Genetic predisposition in female patients with triple‑negative breast cancer. World Acad Sci J 6: 2, 2024.
APA
Kamburova, Z.B., Popovska, S.L., Kovacheva, K.S., Dimitrov, D.D., & Nikolova, S.E. (2024). Genetic predisposition in female patients with triple‑negative breast cancer. World Academy of Sciences Journal, 6, 2. https://doi.org/10.3892/wasj.2023.217
MLA
Kamburova, Z. B., Popovska, S. L., Kovacheva, K. S., Dimitrov, D. D., Nikolova, S. E."Genetic predisposition in female patients with triple‑negative breast cancer". World Academy of Sciences Journal 6.1 (2024): 2.
Chicago
Kamburova, Z. B., Popovska, S. L., Kovacheva, K. S., Dimitrov, D. D., Nikolova, S. E."Genetic predisposition in female patients with triple‑negative breast cancer". World Academy of Sciences Journal 6, no. 1 (2024): 2. https://doi.org/10.3892/wasj.2023.217